JG
4basebio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| opDNA® Platform | DNA template for mRNA therapeutics/vaccines (partner program) | Phase 1/2 |
| Non-viral, cell-targeting nucleic acid delivery platform | Targeted delivery for gene therapy | Pre-clinical |
Leadership Team at 4basebio
DA
Dr. Amy Walker
Chief Executive Officer
CW
Christine Wolosin
Chief Commercial Officer
SL
Scott Lorimer
Chief Operating Officer
JH
Jen Hynes
Vice President, Quality
JV
James Vang
Vice President, Business Development North America
DJ
Daniel Jones
Vice President, Manufacturing & Engineering
MB
Manja Boerman
Executive Chair of the Board
HP
Hansjörg Plaggemars
Non-executive Director
AM
Alan Malus
Independent, Non-executive Director
MW
Michael Wasserman
Non-executive Director